193 related articles for article (PubMed ID: 35634303)
1. Evaluation of an ImmunoPET Tracer for IL-12 in a Preclinical Model of Inflammatory Immune Responses.
Viola NT; Glassbrook JE; Kalluri JR; Hackett JB; Wicker MN; Sternberg J; Gibson HM
Front Immunol; 2022; 13():870110. PubMed ID: 35634303
[TBL] [Abstract][Full Text] [Related]
2. Interferon gamma immunoPET imaging to evaluate response to immune checkpoint inhibitors.
Hackett JB; Ramos N; Barr S; Bross M; Viola NT; Gibson HM
Front Oncol; 2023; 13():1285117. PubMed ID: 38130991
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapeutic intervention with oncolytic adenovirus in mouse mammary tumors.
Gibson H; Munns S; Freytag S; Barton K; Veenstra J; Bettahi I; Bissonette J; Wei WZ
Oncoimmunology; 2015 Jan; 4(1):e984523. PubMed ID: 25949865
[TBL] [Abstract][Full Text] [Related]
4. Non-transmissible Sendai virus encoding granulocyte macrophage colony-stimulating factor is a novel and potent vector system for producing autologous tumor vaccines.
Inoue H; Iga M; Nabeta H; Yokoo T; Suehiro Y; Okano S; Inoue M; Kinoh H; Katagiri T; Takayama K; Yonemitsu Y; Hasegawa M; Nakamura Y; Nakanishi Y; Tani K
Cancer Sci; 2008 Nov; 99(11):2315-26. PubMed ID: 18957055
[TBL] [Abstract][Full Text] [Related]
5. Optimized biodegradable polymeric reservoir-mediated local and sustained co-delivery of dendritic cells and oncolytic adenovirus co-expressing IL-12 and GM-CSF for cancer immunotherapy.
Oh E; Oh JE; Hong J; Chung Y; Lee Y; Park KD; Kim S; Yun CO
J Control Release; 2017 Aug; 259():115-127. PubMed ID: 28336378
[TBL] [Abstract][Full Text] [Related]
6. CD4
Kristensen LK; Fröhlich C; Christensen C; Melander MC; Poulsen TT; Galler GR; Lantto J; Horak ID; Kragh M; Nielsen CH; Kjaer A
Theranostics; 2019; 9(26):8221-8238. PubMed ID: 31754392
[TBL] [Abstract][Full Text] [Related]
7. A preclinical PET dual-tracer imaging protocol for ER and HER2 phenotyping in breast cancer xenografts.
Paquette M; Phoenix S; Lawson C; Guérin B; Lecomte R; Tai LH; Turcotte ÉE; Leyton JV
EJNMMI Res; 2020 Jun; 10(1):69. PubMed ID: 32592121
[TBL] [Abstract][Full Text] [Related]
8. Removal of Fc Glycans from [
White JM; Keinänen OM; Cook BE; Zeglis BM; Gibson HM; Viola NT
Mol Pharm; 2020 Jun; 17(6):2099-2108. PubMed ID: 32330387
[TBL] [Abstract][Full Text] [Related]
9. Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF.
Choi KJ; Zhang SN; Choi IK; Kim JS; Yun CO
Gene Ther; 2012 Jul; 19(7):711-23. PubMed ID: 21993173
[TBL] [Abstract][Full Text] [Related]
10. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model.
Majumdar AS; Zolotorev A; Samuel S; Tran K; Vertin B; Hall-Meier M; Antoni BA; Adeline E; Philip M; Philip R
Cancer Gene Ther; 2000 Jul; 7(7):1086-99. PubMed ID: 10917212
[TBL] [Abstract][Full Text] [Related]
12. Radiolabeled Monoclonal Antibody Against Colony-Stimulating Factor 1 Receptor Specifically Distributes to the Spleen and Liver in Immunocompetent Mice.
Waaijer SJH; Suurs FV; Hau CS; Vrijland K; de Visser KE; de Groot DJA; de Vries EGE; Lub-de Hooge MN; Schröder CP
Front Oncol; 2021; 11():786191. PubMed ID: 34976826
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of a dual cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM expressing tumor cells.
Schanzer JM; Fichtner I; Baeuerle PA; Kufer P
J Immunother; 2006; 29(5):477-88. PubMed ID: 16971804
[TBL] [Abstract][Full Text] [Related]
14. Immuno-PET Monitoring of CD8
Alsaid H; Cheng SH; Bi M; Xie F; Rambo M; Skedzielewski T; Hoang B; Mohanan S; Comroe D; Gehman A; Hsu CY; Farhangi K; Tran H; Sherina V; Doan M; Groseclose MR; Hopson CB; Brett S; Wilson IA; Nicholls A; Ballas M; Waight JD; Jucker BM
Mol Imaging Biol; 2023 Jun; 25(3):528-540. PubMed ID: 36266600
[TBL] [Abstract][Full Text] [Related]
15. In situ recruitment of antigen-presenting cells by intratumoral GM-CSF gene delivery.
Pan PY; Li Y; Li Q; Gu P; Martinet O; Thung S; Chen SH
Cancer Immunol Immunother; 2004 Jan; 53(1):17-25. PubMed ID: 12955480
[TBL] [Abstract][Full Text] [Related]
16. Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody.
Nigam S; McCarl L; Kumar R; Edinger RS; Kurland BF; Anderson CJ; Panigrahy A; Kohanbash G; Edwards WB
Mol Imaging Biol; 2020 Jun; 22(3):685-694. PubMed ID: 31529407
[TBL] [Abstract][Full Text] [Related]
17. Development of [
Ghai A; Zheleznyak A; Mixdorf M; O'Neal J; Ritchey J; Rettig M; DiPersio J; Shokeen M; Achilefu S
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1302-1311. PubMed ID: 33179150
[TBL] [Abstract][Full Text] [Related]
18. Thyroid cancer immuno-therapy with retroviral and adenoviral vectors expressing granulocyte macrophage colony stimulating factor and interleukin-12 in a rat model.
Tanaka K; Towata S; Nakao K; Mizuguchi H; Hayakawa T; Niwa M; Ishii N; Nagayama Y
Clin Endocrinol (Oxf); 2003 Dec; 59(6):734-42. PubMed ID: 14974915
[TBL] [Abstract][Full Text] [Related]
19. PET/CT Imaging of Human TNFα Using [
Beckford-Vera DR; Gonzalez-Junca A; Janneck JS; Huynh TL; Blecha JE; Seo Y; Li X; VanBrocklin HF; Franc BL
Mol Imaging Biol; 2020 Feb; 22(1):105-114. PubMed ID: 31065895
[TBL] [Abstract][Full Text] [Related]
20. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
Hill HC; Conway TF; Sabel MS; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK
Cancer Res; 2002 Dec; 62(24):7254-63. PubMed ID: 12499267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
